CHARLES E MATHER IV Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CHARLES E MATHER IV.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES E MATHER IV. CHARLES E MATHER IV is Director in Tonix Pharmaceuticals Holding Corp. ($TNXP) and Director in EYENOVIA, INC. ($EYEN).
Latest Insider Trading Transactions of CHARLES E MATHER IV
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15 2020 | EYEN | EYENOVIA, INC. | MATHER CHARLES E IV | Director | Option Exercise | A | 3.43 | 9,820 | 33,683 | 9,820 | |
| Sep 15 2020 | EYEN | EYENOVIA, INC. | MATHER CHARLES E IV | Director | Grant | A | 0.00 | 7,288 | 0 | 23,359 | 16.1 K to 23.4 K (+45.35 %) |
| Aug 20 2019 | EYEN | EYENOVIA, INC. | MATHER CHARLES E IV | Director | Option Exercise | A | 3.11 | 9,057 | 28,167 | 9,057 | |
| Aug 20 2019 | EYEN | EYENOVIA, INC. | MATHER CHARLES E IV | Director | Grant | A | 0.00 | 8,038 | 0 | 16,071 | 8 K to 16.1 K (+100.06 %) |
| Sep 20 2018 | EYEN | EYENOVIA, INC. | MATHER CHARLES E IV | Director | Buy | P | 4.78 | 3,000 | 14,340 | 8,033 | 5 K to 8 K (+59.61 %) |
| Sep 20 2018 | EYEN | EYENOVIA, INC. | MATHER CHARLES E IV | Director | Buy | P | 4.80 | 1,000 | 4,800 | 5,033 | 4 K to 5 K (+24.80 %) |
| Jul 26 2018 | EYEN | EYENOVIA, INC. | MATHER CHARLES E IV | Director | Option Exercise | A | 6.20 | 4,465 | 27,683 | 4,465 | |
| Jul 26 2018 | EYEN | EYENOVIA, INC. | MATHER CHARLES E IV | Director | Grant | A | 0.00 | 4,033 | 0 | 4,033 | 0 to 4 K |
| Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | A | 4.25 | 20,000 | 85,000 | 20,000 | |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Buy | M | 0.00 | 600 | 0 | 1,783 | 1.2 K to 1.8 K (+50.72 %) |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Buy | M | 0.00 | 750 | 0 | 2,533 | 1.8 K to 2.5 K (+42.06 %) |
| Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Buy | M | 0.00 | 750 | 0 | 3,283 | 2.5 K to 3.3 K (+29.61 %) |
| Jun 21 2017 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | A | 4.18 | 20,000 | 83,600 | 20,000 | |
| May 31 2016 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| Feb 10 2016 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | A | 0.00 | 7,500 | 0 | 7,500 | |
| Mar 10 2015 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Buy | P | 6.80 | 1,000 | 6,800 | 11,830 | 10.8 K to 11.8 K (+9.23 %) |
| Feb 27 2015 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| Feb 27 2015 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | A | 5.95 | 5,000 | 29,750 | 5,000 | |
| Nov 03 2014 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | A | 6.68 | 5,000 | 33,400 | 5,000 | |
| Jun 20 2014 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | A | 9.87 | 5,000 | 49,350 | 0 | |
| Sep 27 2013 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Buy | P | 3.65 | 1,000 | 3,650 | 10,830 | 9.8 K to 10.8 K (+10.17 %) |
| Sep 09 2013 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Buy | P | 3.48 | 600 | 2,088 | 9,830 | 9.2 K to 9.8 K (+6.50 %) |
| Sep 06 2013 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Buy | P | 3.23 | 451 | 1,457 | 9,230 | 8.8 K to 9.2 K (+5.14 %) |
| Apr 29 2013 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | C | 0.40 | 25,000 | 10,000 | 85,000 | |
| Apr 29 2013 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Buy | C | 0.40 | 25,000 | 10,000 | 175,569 | 150.6 K to 175.6 K (+16.60 %) |
| Feb 20 2013 | TNXP | Tonix Pharmaceutic ... | MATHER CHARLES E IV | Director | Option Exercise | A | 0.51 | 210,000 | 107,100 | 0 |
Page: 1